News
Company news 
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
Company news 
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
Company news 
Oxford Nanopore Technologies collaborates with Twist Bioscience to launch Pharmacogenomics Beta Programme and advance personalised medicine
Company news 
Oxford Nanopore Technologies and UMC Utrecht collaborate on 1,000 human genome sequencing project
Company news 
Oxford Nanopore Technologies and Mahidol University launch first Centre of Excellence in Southeast Asia | Oxford Nanopore Technologies
Company news 
Oxford Nanopore Technologies and Dubai Health to collaborate on genetic screening
Company news 
Oxford Nanopore receives regulatory approval for its first diagnostic device in the UK and Europe
Company news 
Oxford Nanopore launches a 24-hour whole genome sequencing workflow for rare disease research
Company news 
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease | Oxford Nanopore Technologies
Company news 
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
Company news 
Interview: Parent-of-origin genome analysis presents the potential to improve future genetic testing
Company news 
Interview: Advancing long-read de novo genome assembly methods in clinical research
Company news 
Blog: Resolving structural variants causing antithrombin deficiency
Company news 
Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?
Company news 
bioMérieux makes strategic investment in Oxford Nanopore
Company news 
Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development
Company news 
Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032
Company news APAC Rare Disease Consortium launched to advance genomic innovation and rare disease diagnosis
Company news 
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies